Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Bruno Fattizzo

Showing results (11-20 of 135) with videos related to

Pageof 14
Sort By:
Blood Reviews|March 11, 2026
Autoimmune hemolytic anemia: New frontiers in diagnosis and therapyWilma Barcellini, Bruno Fattizzo
Expert Review of Hematology|May 23, 2023
Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemiasWilma Barcellini, Bruno Fattizzo
International Journal of Laboratory Hematology|April 16, 2024
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapyFrancesco Versino, Bruno Fattizzo
Frontiers in Oncology|January 31, 2020
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular AspectsBruno Fattizzo, Wilma Barcellini
Expert Review of Hematology|June 14, 2024
The evolving management algorithm for the patient with newly diagnosed cold agglutinin diseaseWilma Barcellini, Bruno Fattizzo
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 10, 2020
Second-Generation C5 Inhibitors for Paroxysmal Nocturnal HemoglobinuriaBruno Fattizzo, Austin G Kulasekararaj
International Journal of Hematology|March 15, 2026
Thrombosis in paroxysmal nocturnal hemoglobinuria in the complement inhibitor era: mechanisms, risk stratification, and clinical managementBruno Fattizzo, Christoph Q Schmidt
Expert Review of Hematology|July 8, 2026
Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatmentCatherine M Broome, Bruno Fattizzo
Expert Review of Hematology|April 11, 2020
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic proceduresWilma Barcellini, Juri Giannotta, Bruno Fattizzo
Journal of Blood Medicine|September 10, 2019
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectivesWilma Barcellini, Bruno Fattizzo, Anna Zaninoni
Pageof 14

Showing results (11-20 of 135) with videos related to

Sort By:
Pageof 14
Blood Reviews|March 11, 2026
Autoimmune hemolytic anemia: New frontiers in diagnosis and therapyWilma Barcellini, Bruno Fattizzo
Expert Review of Hematology|May 23, 2023
Strategies to overcome the diagnostic challenges of autoimmune hemolytic anemiasWilma Barcellini, Bruno Fattizzo
International Journal of Laboratory Hematology|April 16, 2024
Complement inhibition in paroxysmal nocturnal hemoglobinuria: From biology to therapyFrancesco Versino, Bruno Fattizzo
Frontiers in Oncology|January 31, 2020
Autoimmune Cytopenias in Chronic Lymphocytic Leukemia: Focus on Molecular AspectsBruno Fattizzo, Wilma Barcellini
Expert Review of Hematology|June 14, 2024
The evolving management algorithm for the patient with newly diagnosed cold agglutinin diseaseWilma Barcellini, Bruno Fattizzo
Biodrugs : Clinical Immunotherapeutics, Biopharmaceuticals and Gene Therapy|January 10, 2020
Second-Generation C5 Inhibitors for Paroxysmal Nocturnal HemoglobinuriaBruno Fattizzo, Austin G Kulasekararaj
International Journal of Hematology|March 15, 2026
Thrombosis in paroxysmal nocturnal hemoglobinuria in the complement inhibitor era: mechanisms, risk stratification, and clinical managementBruno Fattizzo, Christoph Q Schmidt
Expert Review of Hematology|July 8, 2026
Sutimlimab for cold agglutinin disease: an updated perspective from approval to real-world clinical treatmentCatherine M Broome, Bruno Fattizzo
Expert Review of Hematology|April 11, 2020
Autoimmune hemolytic anemia in adults: primary risk factors and diagnostic proceduresWilma Barcellini, Juri Giannotta, Bruno Fattizzo
Journal of Blood Medicine|September 10, 2019
Management of refractory autoimmune hemolytic anemia after allogeneic hematopoietic stem cell transplantation: current perspectivesWilma Barcellini, Bruno Fattizzo, Anna Zaninoni
Pageof 14